Search results for tumor
-
Ahmed Mostafa
Ahmed Mostafa MD, MSc, PhD, is Director (in training) of ASHI Certified Histocompatibility, Training Program Tissue Typing Laboratory, Department of Pathology, Laboratory Medicine Calgary, Laboratory Services & at University of Calgary. He is a Member of American Society for Histocompatibility and Immunogenetics (ASHI), Canadian Society for Immunology, Beatrice Hunter Cancer Research Institute, European Association of Cancer Research, American Association of Cancer Research, Canadian Society for Life Science Research, Tumor Microenvironment Working Group and American Society of Clinical Oncology.
-
Annals of Clinical and Laboratory Research
Open Reduction and Internal Fixation to Repair a Lisfranc Injury: A Case Report
Author(s): Nickul N Shah and James DeMeo
-
Journal of Clinical Epigenetics
Epigenetic Alterations in well-Differentiated Thyroid Cancer
Author(s): Mariana Bisarro dos Reis, Caroline Moraes Beltrami, Luiz Paulo Kowaslki and Silvia Regina Rogatto*
-
Annals of Clinical and Laboratory Research
Adipocytokines in Particular Pregnancy Disorders
Author(s): Canverenler Emre, Buke Baris, Akkaya Hatice, Akarsu Suleyman and Isk Ahmet Zeki
-
Health Systems and Policy Research
Implementation and Evaluation of Quality of Care for Pediatric Brain Tumor at a Single University Hospital in Saudi Arabia
Author(s): Alsharydah AM, Alanazi AH, Alsuhaibani SS, Alsayyah AA and Al-Jehani HM
-
Journal of Clinical Epigenetics
A Case Report of Personalized Chemotherapy for Metastatic Cardiac Sarcoma
Author(s): Biaoru Li*, Huasheng Xiao, Yong Gao, Shen Li, Xiaona Zhang, Junsong Han
-
Archives in Cancer Research
Roles Biomarkers in Basic and Clinical Research for Breast Cancer
Author(s): Ehab Abou-eladab, Faten Shehata and Shawgi Albahari
-
Archives of Medicine
Diaphyseal Femoral Fracture Associated with Hyperparathyroidism and Brown Tumor with Sclerotic Bone Response to Parathyroidectomy
Author(s): Fahad Alshahrani, Mussa Almalki, Khalid Khashoggi, Juliet Luna-Algoso, David Kendler
-
Journal of Autoimmune Disorders
U0126, an Inhibitor of MEK1/2, Increases Tumor Necrosis Factor-ÃÆà ½Ãâñ-Induced Apoptosis, but not Interleukin-6 Induced Apoptosis in C-28/I2 Human Chondrocytes
Author(s): Charles J Malemud, Aaron C Lewis, Meredith A Wylie, Evan C Meszaros, Yelenna Skomorovska-Prokvolit, Sam Mesiano